FR2804436B1 - PROTEINE DE FUSION scsCNTFR/NNT-1 - Google Patents

PROTEINE DE FUSION scsCNTFR/NNT-1

Info

Publication number
FR2804436B1
FR2804436B1 FR0013090A FR0013090A FR2804436B1 FR 2804436 B1 FR2804436 B1 FR 2804436B1 FR 0013090 A FR0013090 A FR 0013090A FR 0013090 A FR0013090 A FR 0013090A FR 2804436 B1 FR2804436 B1 FR 2804436B1
Authority
FR
France
Prior art keywords
scscntfr
nnt
fusion protein
fusion
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0013090A
Other languages
English (en)
Other versions
FR2804436A1 (fr
Inventor
Greg Elson
Jean Francois Gauchat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0001035A external-priority patent/FR2804434A1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR0013090A priority Critical patent/FR2804436B1/fr
Priority to PCT/FR2001/000254 priority patent/WO2001055219A2/fr
Priority to AU2001231918A priority patent/AU2001231918A1/en
Publication of FR2804436A1 publication Critical patent/FR2804436A1/fr
Application granted granted Critical
Publication of FR2804436B1 publication Critical patent/FR2804436B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0013090A 2000-01-27 2000-10-12 PROTEINE DE FUSION scsCNTFR/NNT-1 Expired - Fee Related FR2804436B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0013090A FR2804436B1 (fr) 2000-01-27 2000-10-12 PROTEINE DE FUSION scsCNTFR/NNT-1
PCT/FR2001/000254 WO2001055219A2 (fr) 2000-01-27 2001-01-26 PROTEINE DE FUSION scsCNTFR/NNT-1
AU2001231918A AU2001231918A1 (en) 2000-01-27 2001-01-26 Scscntfr/nnt-1 fusion protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001035A FR2804434A1 (fr) 2000-01-27 2000-01-27 Heterocomplexe nnt-1/clf-1 et son utilisation en tant qu'activateur du recepteur complexe cntrfalpha/gp130/lifrbet a
FR0013090A FR2804436B1 (fr) 2000-01-27 2000-10-12 PROTEINE DE FUSION scsCNTFR/NNT-1

Publications (2)

Publication Number Publication Date
FR2804436A1 FR2804436A1 (fr) 2001-08-03
FR2804436B1 true FR2804436B1 (fr) 2002-08-02

Family

ID=26212129

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0013090A Expired - Fee Related FR2804436B1 (fr) 2000-01-27 2000-10-12 PROTEINE DE FUSION scsCNTFR/NNT-1

Country Status (3)

Country Link
AU (1) AU2001231918A1 (fr)
FR (1) FR2804436B1 (fr)
WO (1) WO2001055219A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131103A0 (en) * 1997-02-03 2001-01-28 Amgen Inc The neurotrophic factor nnt-1
WO1999000415A1 (fr) * 1997-06-30 1999-01-07 Human Genome Sciences, Inc. Cytokine de type cardiotrophine

Also Published As

Publication number Publication date
AU2001231918A1 (en) 2001-08-07
WO2001055219A2 (fr) 2001-08-02
WO2001055219A3 (fr) 2002-03-07
FR2804436A1 (fr) 2001-08-03

Similar Documents

Publication Publication Date Title
DK2236152T3 (da) Albuminfusionsproteiner
CY2014040I1 (el) Πρωτεϊνη συντηξης αλβουμινης
DE60144099D1 (de) Tripode-gleichlaufgelenk
ATE322251T1 (de) Neurotoxin implantat
DE60126129D1 (de) Interphalangärer gelenkersatz
DE60140664D1 (de) Schweisssystem
FR2800817B1 (fr) Joint homocinetique tripode
IT1313881B1 (it) Giunto omocinetico
DE60107387D1 (de) Tripodes gleichlaufgelenk
BR0104178B1 (pt) articulação esférica.
BR0104596B1 (pt) articulação esférica.
ATE439376T1 (de) Gag-bindende proteine
ID29577A (id) Protein pestisida
FR2809146B1 (fr) Joint homocinetique
DE60116130D1 (de) Tripode-gleichlaufgelenk
FR2840375B1 (fr) Joint homocinetique tripode
NO20021275D0 (no) Transgent produserte fusjonsproteiner
DE50102987D1 (de) Gelenkhalterung
DE10082298D2 (de) Chimäre Proteine
FI991256A (fi) Apulaite tarjoilua varten
DE60129554D1 (de) Bakterielle insektizidproteine
NO20021244L (no) Subenhet-optimaliserte fusjonsproteiner
DE60117001D1 (de) Nectin-3 proteine
FR2804436B1 (fr) PROTEINE DE FUSION scsCNTFR/NNT-1
DE10084565T1 (de) Verbindungsorgan

Legal Events

Date Code Title Description
ST Notification of lapse